IL6 and COVID-19: Likewise, it has been reported that patients with T2DM and COVID-19 had a higher count of white blood cells, neutrophils, and proinflammatory cytokines (such as IL-6 and TNF-α), suggesting an increased inflammatory response compared to patients without diabetes (Shenoy et al., 2020).